Wisconsin may not be home to any of the major pharmaceutical companies, but they are feeding the state’s economy in other ways, by funding clinical trials of promising drug compounds conducted here, according to a study released Wednesday.
Clinical drug trials in Wisconsin are pumping hundreds of millions of dollars into the state’s economy and directly support tens of thousands of high-paying jobs, according to a study released today by PhRMA, a national trade group representing pharmaceutical companies.
Drug companies have sponsored more than 2,000 clinical trials in Wisconsin since 1999, according to a report released Wednesday by Pharmaceutical Research and Manufacturers of America, or Phrma, the industry’s main trade group.
A new report shows more than 2,000 clinical trials of new medicines have been conducted in Wisconsin since 1999 or currently are under way, including 119 in Marshfield.